- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05509114
The Effect of Virtual Reality Glasses Application on Pain, Anxiety, and Patient Satisfaction
August 18, 2022 updated by: Rumeysa Lale TORAMAN, Ataturk University
The Effect of Virtual Reality Glasses Application on Pain, Anxiety, and Patient Satisfaction During a Transrectal Prostate Biopsy: A Randomized Controlled Trial
The study was conducted in a randomized controlled manner to determine the effect of applying virtual reality glasses during transrectal prostate biopsy on pain, anxiety and patient satisfaction.The study was completed with a total of 70 patients, 35 in the intervention group and 35 in the control group, for whom it was decided to perform sample transrectal prostate biopsy for the first time.
Study Overview
Detailed Description
Although prostate cancer is the most common type of cancer in men, according to 2018 data published by the International Agency for Research on Cancer, it is the second most common after lung cancer worldwide.The prevalence of prostate cancer is increasing rapidly worldwide.
However, when prostate cancer is diagnosed early, the survival rate increases with the effect of the treatment methods applied.
Digital rectal examination (DRE), prostate specific antigen (PSA) level, and transrectal ultrasonography-guided prostate biopsy (TRUS-Bx) methods are used for diagnosis.
Transrectal prostate biopsy process; It is one of the most frequently performed urological procedures for definitive diagnosis in patients with a PSA value above the normal limit and abnormal DRE findings.
Transrectal prostate biopsy is a golden diagnostic tool in prostate cancer because it is typically well tolerated, treatable, and has a low risk of major complications.
However, in addition to the advantages of this procedure, it also has disadvantages such as causing pain and discomfort in patients.Prostate biopsy procedure affects patients not only physiologically but also psychologically.
Interventional procedures cause patients to experience the highest level of anxiety.
With the development of technology, developments in health care have brought the concept of patient satisfaction to the fore.
Applications made in line with patient expectations in order to increase the quality of care make a significant contribution to the perception of nursing care.
One of these applications, virtual reality glasses, make patients feel like they are in a different world; increases patient satisfaction.
Nurses, who are members of the profession who plan and manage care, because they spend longer time with the patient; They play an active role in defining pain and anxiety by using pharmacological and non-pharmacological methods.
When examining the literature, there was no study examining the effect of virtual reality application on the pain level of patients during the transrectal prostate biopsy procedure, but no study examining the effect on the level of anxiety and patient satisfaction.
In this study; It is aimed to increase patient satisfaction by reducing the pain and anxiety of the patients with virtual reality applied during the transrectal prostate biopsy procedure.
It is thought that the results of this study can make an important contribution to both the literature and practice.
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Erzurum
-
Palandöken, Erzurum, Turkey, 25000
- Rumeysa Lale TORAMAN
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Those between the ages of 18-65,
- Those who volunteer and accept to participate in the research,
- Transrectal prostate biopsy procedure performed for the first time,
- No communication problem,
- Cognitive level scales are suitable for application,
- Patients without vision or hearing problems were included in the study.
Exclusion Criteria:
- Leaving work voluntarily,
- Patients whose cognitive level scales were not suitable for application were excluded from the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Virtual Reality Glasses
The intervention introductory information formula was face-to-face by researchers from the State-Trait Anxiety Inventory (STAI-I, STAI-II), the Scale of Patient Perception of Hospital Experience with Nursing Care (PPHEN) and Visual Analog Scale for Pain (VAS) Before starting the research, a preliminary application plan is determined with 10 virtual virtual applications.
It is not included in the applications made in the pre-application.
Before watching the video, patients are informed about how to train, how to do it, and detailed information about the video.
When the patient is removed from the service and in the left lateral position, 2 minutes before the assistant physician, the virtual is about to take place.
The video was watched after about 10-15 minutes until the process was finished.
After the procedure, STAI-I, STAI-II, PPHEN and VAS were reapplied by the researchers.
|
The intervention group of patients watched a video with virtual reality glasses during the transrectal biopsy process.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
State-Trait Anxiety İnventory (STAI-I, STAI-II)
Time Frame: up to 24 hours
|
It is a test developed by Spielberger et al. that measures state and trait anxiety levels.
Its validity and reliability in Turkey was done by Öner and Le Compte.
The scale consists of two parts, the 'state anxiety scale', which is created with the aim of determining the instantaneous feelings, and the 20-item 'trait anxiety scale', which was created to determine the feelings in general.
It is a four degree scale ranging from 'Nothing' to 'All'.
Scores range from 20 (low anxiety) to 80 (high anxiety).
|
up to 24 hours
|
|
The Scale of Patient Perception of Hospital Experience with Nursing Care (PPHEN)
Time Frame: up to 24 hours
|
The patient's perception of nursing care scale was developed by Dozier et al. in the USA, and its Turkish validity and reliability were determined by Çoban and Kaşıkçı.Likert-type scale has 15 statements about the quality of nursing care.
A minimum of 15 and a maximum of 75 points can be obtained from the scale.
The cut-off point of the scale is 45.
Scores above the cut-off point indicate a positive attitude.
The increase in the total score obtained from the scale indicates that the patient is satisfied with the nursing care.
|
up to 24 hours
|
|
Visual Analog Scale for Pain (VAS)
Time Frame: up to 24 hours
|
VAS is a scale developed by Price et al34 (1983) and measures the severity of pain in the patient.
VAS is a 10 cm long vertical or horizontal scale with two different names (0=no pain, 10=most severe pain).
An increase in the score obtained from the scale in the evaluation indicates an increase in pain.
|
up to 24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: RUMEYSA LALE TORAMAN, Ataturk University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 25, 2021
Primary Completion (Actual)
June 20, 2022
Study Completion (Actual)
July 27, 2022
Study Registration Dates
First Submitted
August 17, 2022
First Submitted That Met QC Criteria
August 18, 2022
First Posted (Actual)
August 19, 2022
Study Record Updates
Last Update Posted (Actual)
August 19, 2022
Last Update Submitted That Met QC Criteria
August 18, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Rumeysa
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostate
-
Mayo ClinicNot yet recruitingProstate Cancer | Metastatic Prostate Cancer | Prostate Adenocarcinoma | Advanced Prostate Cancer | Localized Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Adenocarcinoma of the Prostate | Metastatic Prostate Adenocarcinoma | Advanced Prostate Adenocarcinoma | Recurrent Prostate Adenocarcinoma | Castration-Sensitive Prostate Cancer and other conditionsUnited States
-
Cancer Institute and Hospital, Chinese Academy...RecruitingProstate Cancer Castration-resistant Prostate CancerChina
-
Roswell Park Cancer InstituteRecruitingObesity | Overweight | Cancer Survivor | Prostate Adenocarcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage A Prostate Cancer | Stage... and other conditionsUnited States
-
University of California, IrvineCompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Regeneron Pharmaceuticals; Prostate Cancer FoundationWithdrawnStage III Prostate Cancer | Stage IV Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage IIIA Prostate Cancer | Stage IIIB Prostate Cancer | Stage IIIC Prostate Cancer
-
University of Southern CaliforniaNational Cancer Institute (NCI); SanofiTerminatedDiarrhea | Recurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Ohio State University Comprehensive Cancer CenterRiverside Methodist HospitalCompletedStage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteGenentech, Inc.CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Ryan Kohlbrenner, MDRadiological Society of North AmericaCompletedProstate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Prostate Carcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage...United States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedProstate Adenocarcinoma | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
Clinical Trials on Virtual Reality Glasses
-
Cihat OzyılmazCompletedChild | Anxiety | FearTurkey
-
Yuzuncu Yil UniversityCompletedHyperthyroidism | Virtual RealityTurkey (Türkiye)
-
Ankara Yildirim Beyazıt UniversityCompletedVirtual Reality | Education | Bariatric Surgery | NursingTurkey (Türkiye)
-
Biruni UniversityCompleted
-
Saglik Bilimleri UniversitesiCompletedPain | Anxiety | Gastro-Intestinal DisorderTurkey
-
Necmettin Erbakan UniversityHealth Institutes of TurkeyCompleted
-
Özlem ÇiçekIzmir Bakircay UniversityCompletedEpisiotomy WoundTurkey
-
Istanbul Sabahattin Zaim UniversityCompleted
-
Esra DOĞAN YILMAZ, RN, MScCompletedThe Effects of Virtual Reality Glasses on Vital Signs and Anxiety in Patients Undergoing ColonoscopyAnxiety | Colonoscopy | Vital SignsTurkey
-
Saglik Bilimleri UniversitesiUnknown